Company:  ELECTROCORE, INC. (ECOR)
Form Type:  8-K
Filing Date:  6/23/2022 
CIK:  0001560258 
Address:  200 FORGE WAY
SUITE 205
 
City, State, Zip:  ROCKAWAY, New Jersey 07866 
Telephone:  973-290-0097 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.29  
Change: 
0.016 (5.86%)  
Trade Time: 
10:27 AM EST  
Market Cap: 
$20.57M
Trade ECOR now with

© 2022  
Description of Business
We are a commercial stage medical device company with a proprietary non-invasive vagus nerve stimulation, or nVNS, therapy. nVNS is a platform bioelectronic medical therapy that modulates neurotransmitters through its effects on both the peripheral and central nervous systems. Our gammaCore treatment is the first FDA-cleared, prescription-only nVNS therapy. Historically, vagus nerve stimulation, or VNS, required an invasive surgical procedure to permanently implant a costly medical device. This limitation has generally prevented VNS from being used, other than by the most severe patients. Our lead product, gammaCore Sapphire, is a proprietary, simple-to-use handheld delivery system intended for multi-year use. Currently, it is largely prescribed on a timed basis in 31-day or 93-day increments, or with a predefined number of stimulations, in a Durable Medical Equipment, or DME, configuration and may be both rechargeable and reloadable.
Register and access this filing in:     
  FORM 8-K
    SECTION 3 SECURITIES AND TRADING MARKETS
      Item 3.01 Notice of Delisting or Failure to Satisfy a ...
    SECTION 9 FINANCIAL STATEMENTS AND EXHIBITS
      Item 9.01 Financial Statements and Exhibits.
    SIGNATURES
  EXHIBIT 99.1